Clinical Trial Update: Cell Therapy With Bone Marrow Mononuclear Cells in Critical Leg Ischemia (CLI) [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating autologous bone marrow mononuclear cell therapy for critical limb ischemia. The sponsor is Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Bone marrow mononuclear cell therapy (bone marrow mononuclear cells)

Snippet

Sponsor: University of Paris 5 - Rene Descartes | Conditions: Critical Leg Ischemia | Phase 1 | Status: UNKNOWN